• COVIDIEN LTD Financial Overview

  • Income Statement: COV

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 10.17 B 9.65 B 523.00 M 5.14%
    Gross Profit 4.84 B 4.49 B 351.00 M 7.26%
    Net Income Before Extra Items/Preferred Div -342.00 M 1.30 B -1.65 B 481.29%
    Operating Income 2.08 B 2.14 B -64.00 M -3.08%
  • Cash Flow: COV

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing 110.00 M -1.18 B 1.29 B 1,170.00%
    Net Cash Flow - Investing 1.71 B -67.00 M 1.78 B 103.92%
    Net Cash Flow/Operating Activities 2.21 B 1.20 B 1.00 B 45.50%
  • Balance Sheet: COV

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 18.25 B 14.30 B 3.95 B 21.64%
    Total Liabilities 11.50 B 7.50 B 4.01 B 34.85%
    Shareholders Equity 6.74 B 6.80 B -61.00 M -0.90%
  • Key Ratios / Statistics: COV

    • Valuation

      Price/Earnings (TTM)
      Price/Sales (TTM) 2.16
      Price/Book (MRQ) 3.08
      Price/Cash Flow (TTM) 17.09
    • Profitability

      Gross Margin 47.56
      Operating Margin 20.44
      Profit Margin -3.36
    • Dividends

      Dividend Paid (TTM) 0.64
      Payout Ratio % (TTM) 30.48
    • Financial Strength

      Quick Ratio (MRQ) 0.82
      Current Ratio (MRQ) 2.76
      Long Term Debt-to-Equity (MRQ) 41.04
    • Management Effectiveness

      Return on Equity (TTM)
      Return on Assets (TTM) 6.63
      Return on Investments (TTM) -1.99